/
ALBBY
$8.46+$0.54 (+6.82%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$7.83 – $19.45
5% from low
Exchange
OTC Link
ADRC
Borrow rate
0.32%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-8.09
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.10B | $9.60B | $15.52B | $20.58B | $26.76B | $27.03B | $30.60B | $33.19B |
| Cost of revenue | $3.77B | $7.37B | $11.90B | $16.47B | $21.06B | $21.13B | $23.17B | $25.24B |
| Gross profit | $1.33B | $2.23B | $3.62B | $4.11B | $5.70B | $5.90B | $7.43B | $7.96B |
| Gross margin | 26.1% | 23.2% | 23.3% | 20.0% | 21.3% | 21.8% | 24.3% | 24.0% |
| R&D | $219.0M | $252.8M | $423.6M | $728.8M | $677.8M | $705.4M | $720.1M | $763.9M |
| Operating income | −$98.2M | −$67.4M | $58.6M | −$1.10B | −$31.8M | $640.2M | $1.58B | $1.78B |
| EBITDA | −$94.2M | −$53.0M | $52.1M | −$188.1M | −$24.5M | $999.0M | $1.62B | $1.83B |
| Net income | −$81.9M | −$6.6M | $348.6M | −$265.6M | $535.7M | $883.5M | $1.43B | $1.88B |
| Net margin | -1.6% | -0.1% | 2.2% | -1.3% | 2.0% | 3.3% | 4.7% | 5.7% |
| EPS (diluted) | -0.15 | -0.01 | 0.52 | -0.39 | 0.79 | 1.25 | 1.78 | 2.40 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $38.7B | $0.00 | $0.00–$0.00 | 0 |
| 2028 | $42.8B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$3.97
Price
$8.46
Implied downside
-53%
Peer comparison
ALIBABA HEALTH UNSP/ADR
ALIBABA HEALTH UNSP/ADR
Held by traders on TradeandTell
No one on the platform currently holds ALBBY.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ALBBY as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ALBBY yet.
